Study Title: Phase I trial of azacitidine plus nivolumab following reduced-intensity allogeneic PBSC transplantation for patients with AML and high-risk myelodysplasia. Big Ten Cancer Research Consortium BTCRC-AML18-342
 

• Status: Terminated Early
• Participating Sites:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • Holden Comprehensive Cancer Center, University of Iowa
• Learn more:
  • clinicaltrials.gov: NCT04128020